StonvexLoading…
StonvexStonvexStonvexCore line items from NVTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $45.92M | $83.30M | $79.46M | $37.94M |
Operating Income | $-107.76M | $-130.68M | $-118.13M | $-123.64M |
Net Income | $-116.95M | $-84.60M | $-145.43M | $73.91M |
EPS (Diluted) | $-0.57 | $-0.46 | $-0.86 | $0.51 |
Total Assets | $500.47M | $389.98M | $485.55M | $425.26M |
Total Liabilities | $56.81M | $41.97M | $104.93M | $40.50M |
Cash & Equivalents | $236.86M | $86.74M | $151.89M | $110.34M |
Free Cash Flow OCF − CapEx | $-44.37M | $-65.59M | $-46.16M | $-49.14M |
Shares Outstanding | 205.57M | 182.46M | 179.20M | 153.63M |